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ABSTRACT
An expanded hexanucleotide repeat in a noncoding region of the C9orf72 gene is a major cause
of amyotrophic lateral sclerosis (ALS), accounting for up to 40% of familial cases and 7% of spo-
radic ALS in European populations. We have generated induced pluripotent stem cells (iPSCs)
from fibroblasts of patients carrying C9orf72 hexanucleotide expansions, differentiated these to
functional motor and cortical neurons, and performed an extensive phenotypic characterization.
In C9orf72 iPSC-derived motor neurons, decreased cell survival is correlated with dysfunction in
Ca21 homeostasis, reduced levels of the antiapoptotic protein Bcl-2, increased endoplasmic
reticulum (ER) stress, and reduced mitochondrial membrane potential. Furthermore, C9orf72
motor neurons, and also cortical neurons, show evidence of abnormal protein aggregation and
stress granule formation. This study is an extensive characterization of iPSC-derived motor neu-
rons as cellular models of ALS carrying C9orf72 hexanucleotide repeats, which describes a novel
pathogenic link between C9orf72 mutations, dysregulation of calcium signaling, and altered pro-
teostasis and provides a potential pharmacological target for the treatment of ALS and the
related neurodegenerative disease frontotemporal dementia. STEM CELLS 2016;34:2063–2078
SIGNIFICANCE STATEMENT
Alterations in the C9orf72 gene have been identified as the most common underlying genetic
abnormality in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) patients,
accounting for approximately 40% of familial cases and providing a clear link between the two
conditions. This study represents an extensive characterization of the cellular processes affected
by alterations in C9orf72 using iPS-derived motor neurons and cortical neurons from ALS/FTD
patients. Our study revealed that the C9orf72 mutation induces disease-specific alterations in
intracellular calcium dynamics, changes in morphology of essential cellular compartments,
along with high levels of protein aggregates in both affected cell types. Our observations repre-
sent the first direct comparison between iPS-derived motor neurons and cortical neurons of
C9orf72 cases, and they provide the foundation for further studies of the mechanism of the
disease causing mutation and for the exploration of disease-modifying therapies.
INTRODUCTION
A hexanucleotide (GGGGCC) expansion in the
first intron of the C9orf72 gene accounts for
approximately 40% of cases of familial amyotro-
phic lateral sclerosis (ALS), up to 7% of sporadic
ALS, and approximately 20% of familial fronto-
temporal lobar degeneration, establishing a firm
genetic link between ALS and frontotemporal
dementia (FTD) [1–3]. The expansion is located
in an intronic or promoter region upstream of
the C9orf72 coding sequence, and the number
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of (GGGGCC)n hexanucleotide repeats ranges between 100 and
4,000 repeats in patients [1, 2, 4]. C9orf72-associated cases
exhibit distinctive neuropathological changes characterized by
abundant cytoplasmic and intranuclear inclusions immunoposi-
tive for ubiquitin and sequestosome-1/p62, suggesting dis-
rupted protein degradation [5–7].
While the function of the C9orf72 gene and the patho-
genic mechanisms of the hexanucleotide expansion are cur-
rently unknown, several hypotheses have been proposed. A
toxic gain of function mechanism, mediated by the accumula-
tion of (GGGGCC)n-rich RNA transcripts within nuclear foci
observed in the frontal cortex and spinal cord of patients,
might lead to sequestration of RNA binding proteins and dis-
ruption of the translation of diverse mRNAs [1] or increased
nucleolar stress [8]. Alternatively, reduced transcription of
C9orf72 could lead to neurodegeneration by interfering with
the constitutive function of the protein [1, 9]. Lastly, repeat-
associated non-ATG (RAN) translation, occurring in the
absence of an initiating ATG codon, over the GGGGCC repeat
expansion has been shown to produce homopolymeric pro-
teins prone to aggregation [10, 11].
The generation of human motor neurons (MNs) in culture
from induced pluripotent stem cells (iPSC), reprogrammed
from skin fibroblasts of patients with neurodegenerative dis-
eases such as ALS, offers a potentially powerful tool with
which to study the key pathological processes in MN degener-
ation and for screening drugs of potential therapeutic benefit.
Previous studies have demonstrated that RNA foci and RAN-
translation products can be detected in iPSC-derived MNs
from ALS/FTD patients with C9orf72 hexanucleotide expan-
sions [12–14]. Evidence of defects in autophagy, sequestration
of RNA-binding proteins by the expanded repeat, changes in
gene transcription, and altered neuronal excitability suggest
that these models can display disease-relevant phenotypes
which can be corrected by targeting the expanded RNA with
antisense oligonucleotides [13, 14].
Calcium (Ca21) dysregulation is believed to play an impor-
tant role in the pathophysiology of ALS [15], and Ca21 over-
load in the cytoplasm of neurons is a potential mechanism
that may link excitotoxicity to neuronal death [16]. The endo-
plasmic reticulum (ER) is the largest intracellular Ca21 store
and high ER Ca21 concentration plays an essential role in the
activity of protein synthesis and processing. Disturbances in
ER Ca21 homeostasis have been linked to chronic activation
of the ER stress response and downstream compensatory
mechanisms to protect the cell, such as the unfolded protein
response (UPR) and autophagy [17]. ER-stress induced cell
death can proceed in both Ca21-dependent and Ca21-inde-
pendent ways. The antiapoptotic proteins Bcl-2 and Bcl-XL are
essential modulators of Ca21 signaling in the cell, mediating
the decrease and release of Ca21 in the ER thereby protecting
mitochondria from Ca21 overload [18, 19].
In order to explore whether altered Ca21 homeostasis and
ER stress are cellular phenotypes associated with C9orf72-
related ALS/FTD, we generated iPSC lines from skin fibroblasts
from patients carrying C9orf72 hexanucleotide expansions and
differentiated them to MNs and cortical neurons (CNs). Here
we show that in C9orf72 iPSC-derived MNs loss of Ca21
homeostasis is associated with a decrease in mitochondrial
potential and increase in ER stress. Increased susceptibility to
cell death was accompanied by reduced levels of the antia-
poptotic Bcl-2 and Bcl-XL proteins and upregulation of the
proapoptotic protein BAK. Furthermore, both C9orf72 MNs
and CNs showed elevated levels of SQST-1/p62 and the for-
mation of poly-A-binding protein (PABP) positive stress gran-
ules. Our results indicate disease-specific alterations in MNs
and CNs of ALS/FTD patients carrying C9orf72 repeat expan-
sions and reveal a novel pathogenic link between C9orf72,
Ca21 dysregulation, ER stress, and loss of proteostasis.
MATERIALS AND METHODS
Ethics Statement
The human iPSC lines used for this study were derived from
human skin biopsy fibroblasts, following signed informed con-
sent, with approval from the South East Wales Research Ethics
Committee (REC ref no. 12/WA/0186) and the South Central
Berkshire Research Ethics Committee, U.K. (REC 10/H0505/71).
Generation and Culture of iPSC Lines
In this study, we used six iPSC-derived lines from four healthy
controls: NHDF-1; OX3-9; OX1 clones 19 and 61; AH017
(clones 3 and 13) and six lines from 3 C9orf72 patients: C9-T2
(clones 6 and 7); C9-7245 (clones 1 and 3); C9-02 (clones 2
and 10). All iPSC lines were derived from skin biopsy fibro-
blasts in the James Martin Stem Cell Facility, University of
Oxford, under standardized protocols to minimize any poten-
tial variation attributable to laboratory differences and/or
handling. Fibroblasts tested negative for mycoplasma using
MycoAlert (Lonza, United kingdom, www.lonza.com/) and the
derived iPSC lines also tested negative using the same test.
The control iPSC line iPS-NHDF-1 [44 year-old female] [20]
and iPS-OX1-19 [36M] [21], derived with Yamanaka retrovi-
ruses, have been published previously. C9-T2-6, C9-T2-7
[62M], 7245-1, 7245-3 [48F] and the control lines iPS-OX3-9
[49M] and iPS AH017-13 [67F] (previously published [22])
were derived using the SeVdp(KOSM)302L Sendai virus system
[23, 24]. This contains the genes for all four reprogramming
transcription factors (Klf4, Oct4, Sox2, c-Myc) expressed from
a single transcript, packaged into a single Sendai virus, ensur-
ing consistency of gene dosage ratio. Sendai virus is a nega-
tive strand RNA virus that is retained in the cytoplasm. As
such, the likelihood of insertion of genetic material into the
genome is negligible. This version of the system also contains
a target for mir302; mir302 is expressed in pluripotent cells,
but not in the originating fibroblasts, so the viral RNA will be
detected and degraded once the cells have reprogrammed to
pluripotency, ensuring complete removal of exogenous genetic
material within a few passages. AH017-13 [67F], OX1-61
[36M], C902-02, C902-10 [62F] were derived using the com-
mercially available Sendai virus-based reprogramming system
Cytotune, which contains the reprogramming genes Klf4,
Oct4, Sox2, c-Myc packaged into individual viruses (Life Tech-
nologies, Rockville, MD, http://www.lifetech.com, used accord-
ing to the manufacturer’s instructions).
Transduced fibroblasts were transferred onto mitotically
inactivated mouse embryonic feeder cells (MEFs; derived in-
house from outbred Swiss mice established and maintained at
the Department of Pathology, Oxford [25, 26], or MEFs pur-
chased from Merck, Whitehouse Station, NY, http://www.
merck.com, derived from CF1 mice) on 0.1% gelatin coated
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plates on day 2 and were cultured in iPS medium consisting
of knock-out Dulbecco’s modified Eagle’s medium (DMEM)
(Invitrogen, Carlsbad, CA, http://www.invitrogen.com), 10%
knock-out-serum replacement (Invitrogen), 2 mM Glutamax-I
(Gibco, Grand Island, NY, http://www.invitrogen.com), 100 U/
mL penicillin (Invitrogen), 100 mg/mL streptomycin (Invitro-
gen), 1% nonessential amino acids (Invitrogen), 0.5 mM b-
mercaptoethanol (Invitrogen), 10 ng/mL basic fibroblast
growth factor (bFGF) (R&D, Minneapolis, http://www.rndsys-
tems.com). Medium was replaced (50%) daily, and substituted
with MEF-conditioned medium from day 10 onward. Colonies
displaying iPSC morphology were picked on day 21–28 and
transferred onto MEFs by manual dissection every 5–7 days.
iPSC lines were adapted to feeder-free conditions onto
Matrigel-coated plates (BD Matrigel hESC-qualified Matrix) in
mTeSR1 (100% daily medium change, StemCell Technologies,
Vancouver, BC, Canada, http://www.stemcell.com). Bulk and
routine passaging was by 0.5 mM EDTA [27] to make large-
scale, quality-controlled, cryopreserved master-stocks
(between p10 and 20). The initial master-stock underwent all
the QC tests described, and all subsequent submaster-stocks
underwent single nucleotide polymorphism (SNP) analysis for
tracking and genome integrity. The number of feeder-free pas-
sages was kept to a minimum, to ensure that differentiation
experiments were set up within a narrow window of passage
numbers. If single-cell dissociation was required for particular
applications, medium was supplemented with Rock inhibitor
Y27632 (10 mM; Calbiochem, San Diego, CA, http://www.emd-
biosciences.com) on the day of passage.
Assessment of Genome Integrity and Tracking
Genome integrity was assessed by Illumina Human CytoSNP-
12v2.1 beadchip array (300,000 markers) or Illumina
HumanOmniExpress-24 (700,000 markers) and analyzed using Kar-
yoStudio and GenomeStudio software (Illumina). SNP deviations
in the iPSC lines were compared to the original pool of fibroblasts.
This also confirmed the identity of the iPSC to the original fibro-
blasts. SNP datasets have been deposited in Gene Expression
Omnibus (GEO) under the accession number GSE64582.
Sendai Clearance Assay
Clearance of Sendai virus from reprogrammed cell lines was
confirmed by polymerase chain reaction (PCR). RNA was
extracted using an RNeasy kit (Qiagen, Hilden, Germany,
http://www1.qiagen.com) from iPSC, from fibroblasts (nega-
tive control), and from fibroblasts infected with Sendai
reprogramming viruses 5 days previously (positive control).
Reverse transcription was carried out using a RetroScript kit
(Ambion, Austin, TX, http://www.ambion.com), using 2 mg
template RNA in 20 mL reaction volume. 2 mL of 1:10 dilution
of cDNA product was used in a 25 mL PCR reaction. For lines
reprogrammed with SeVdp(KOSM)302L, quantitative reverse
transcriptase PCR (qRT-PCR) was carried out on an Applied
Biosystems StepOne Plus Real Time PCR machine, with Ste-
pOne software, using Applied Biosystems 23SYBR green PCR
mix1ROX and 60 degree Celsius anneal. Target gene transcript
levels were compared to actin b control (actin b primers,
Eurogentec) and subsequently to the positive control [28].
Sendai-specific primers were 50-AGACCCTAAGAGGACGAAG
ACAGA-30 and 50-ACTCCCATGGCGTAACTCCATAG-30. For lines
reprogrammed with the Cytotune Sendai reprogramming
system, PCR was carried out according to the manufacturers’
instructions, with a primer pair for each of the four reprog-
ramming viruses and also for the backbone, using actin b as a
positive control for each line (actin b primers, Eurogentec),
and products were visualized by running on a 1.5% agarose
gel with ethidium bromide, and 2-log ladder or 100 bp ladder
(New England Biolabs). Primer pairs were: SeV F: GGA TCA
CTA GGT GAT ATC GAG C; R: ACC AGA CAA GAG TTT AAG AGA
TAT GTA TC; SOX2 F: ATG CAC CGC TAC GAC GTG AGC GC; R:
AAT GTA TCG AAG GTG CTC AA; KLF4 F: TTC CTG CAT GCC AG
A GGA GCC C; R: AAT GTA TCG AAG GTG CTC AA; c-MYC F:
TAA CTG ACT AGC AGG CTT GTC G; R: TCC ACA TAC AGT CCT
GGA TGA TGA TG; OCT4F: CCC GAA AGA GAA AGC GAA CCA G;
R: AAT GTA TCG AAG GTG CTC AA.
PluriTest
RNA was extracted from iPSC using an RNeasy kit (Qiagen) for
Illumina HT12v4 transcriptome array analysis. The data files
were then uploaded to www.pluritest.org and scored for pluri-
potency, as previously described. The Illumina HT12v4 tran-
scriptome array results have been deposited in the GEO
under accession number GSE64583.
Flow Cytometry
iPSC lines were assessed for expression of pluripotency
markers by flow cytometry. Cells were lifted with TrypLE (Life
Technologies), fixed with 4% paraformaldehyde (PFA) in
phosphate-buffered saline (PBS) for 10 minutes then perme-
abilized in methanol at 2208C. 0.5–1 3 106 cells were then
washed and stained in flow cytometry buffer consisting of
PBS, human IgG (10 mg/mL Sigma), fetal calf serum (FCS) (1%
Hyclone, Logan, UT, http://www.hyclone.com), and sodium
azide (0.01%), with an antibody or an isotype-matched control
(with same fluorophore, from the same manufacturer, at 1 mg
antibody per million cells) for 30 minutes. After the primary
staining, cells were washed three times, and fluorescence was
measured using a FACS Calibur (Becton Dickinson, Franklin
Lakes, NJ, http://www.bd.com)—data from 10,000 cells were
collected and analyzed using FlowJo software, gated on
forward scatter-side scatter (FSC-SSC) dot plots, and plotted
as histograms (y axis normalized to mode). The following anti-
bodies (clone, isotype control, supplier) were used: TRA-1-60
(B119983, IgM-488, Biolegend), NANOG (D73G4, IgG-647, Cell
Signaling Technology, Beverly, MA, http://www.cellsignal.com).
Differentiation of iPSCs to MNs
MNs were differentiated from iPSCs using three different pre-
viously published protocols, with several modifications [29,
30]. In one of the differentiation protocols, the differentiation
process was initiated by neural induction of embryoid bodies
(EBs) and was followed by neural progenitor stages and neu-
ral maturation. After 4 days in neural induction medium, the
EBs were plated onto Geltrex-coated plates, and caudalization
of the neural progenitors was obtained by addition of retinoic
acid (RA) to the neural differentiation medium at a concentra-
tion of 0.1 lM. After 10 days, the colonies displaying neural
rosettes structures were isolated and expanded in suspension
in the form of neurospheres in the presence of the ventraliz-
ing growth factor, sonic hedgehog at a concentration of 100
ng/mL. The protocol was modified at this step to enhance cell
survival by addition of Rock inhibitor Y27632, which prevents
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cell detachment and is a widely used supplement in stem cell
cultures [31, 32]. After 2 weeks of culture as neurospheres,
the cells were plated on Geltrex-coated coverslips, and termi-
nal differentiation was induced by addition of brain derived
neurotrophic factor (BDNF 10 ng/mL), glial-derived neurotro-
phic factor (GDNF, 10 ng/mL), insulin-like growth factor (IGF-
1, 10 ng/mL), cyclic AMP (cAMP), and ascorbic acid 0.5lM,
Sigma ascorbic acid. The differentiating MNs were cultured for
another 3–4 weeks before functional assays were performed.
Using the second differentiation protocol [30], the iPSCs
were cultured as monolayers, and neural induction was
started by addition of compound c (1 lM) Tocris Bioscience,
Bristol UK, https://www.tocris.com/ in DMEM/F12 and Neuro-
basal medium, supplemented with N2, B27, Heparin 0.2%.
After 3 days, the medium was supplemented with RA (1 mM)
and after another 3 days, smoothened agoinst (SAG) and pur-
morphamine (1 mM) were added and compound c removed.
After 9 days in culture, the neural precursors were replated at
a low density for differentiation and the medium was supple-
mented with the growth factors BDNF, GDNF and IGF-1 (10
ng/mL), ascorbic acid and cAMP. After 20 days, the MNs were
replated for experiments and allowed to mature for another
3–4 weeks before functional experiments.
MNs were differentiated using a third differentiation pro-
tocol [33], with extensive modifications. Monolayers of iPSCs
were induced in DMEM/F12/Neurobasal with N2 supplement,
B27 supplement, ascorbic acid (0.5 mM), 2-mercaptoethanol
(13), compound C (3 mM). and Chir99021 (3 mM) for 4 days.
After 4 days in culture, RA (1 mM) and SAG (500 nM) were
added to the medium. The next day, Chir99021 and com-
pound C were removed from the medium, and the cells were
cultured for another 4–5 days. Neural precursors were then
dissociated and plated at a low density for 7 days. The
medium was supplemented with growth factors BDNF (10 ng/
mL), GDNF (10 ng/mL), N-[N-(3,5-Difluorophenacetyl)-L-ala-
nyl]-S-phenylglycine t-butyl ester (DAPT) (10 mM), and laminin
(0.5 mg/mL). After 7 days, DAPT and laminin were removed
from the medium, and the neurons were allowed to mature
for another 2–4 weeks before functional experiments.
Differentiation of iPSCs to CNs
The differentiation of iPSCs to CNs was performed following a
previously established protocol [34]. Briefly, the iPSCs were
grown on Matrigel as monolayers, and neural differentiation
was induced by changing the medium to basic neural medium
DMEM/F12: Neurobasal 1:1, 13 N2, 13 B27, insulin 5 mg/mL
(Sigma), nonessential amino acids 100 mM (Life Technologies),
2-mercaptoethanol 100 mM, antibiotic-antimycotic (Life Tech-
nologies) and supplementing it with 500 ng/mL Noggin
(PeproTech, Rocky Hill, NJ, http://www.peprotech.com), and
10 mM SB431542 (Enzo Life Sciences). Medium was changed
every 24 hours until neural rosettes could be observed (12–16
days). The neuroepithelial layer was lifted using Dispase (Life
Technologies), and the medium was supplemented with 20
ng/mL Fibroblast growth factor 2 (FGF2) (PeproTech) for 4–6
days. The neural precursors were split using Accutase (Life
Technologies) at a low density. The medium was then supple-
mented with 10 ng/mL BDNF and 10 ng/mL GDNF, while
FGF2 was withdrawn. The neurons were allowed to extend
processes and to mature for 60–70 days before functional
assays.
Immunocytochemistry
Mature MNs and CNs were fixed with 4% PFA-PBS for 15
minutes and incubated with 10% goat serum for blocking for
1 hour at room temperature. The cells were incubated over-
night at 48C with rabbit anti-cleaved-caspase-3 (Cell Signaling,
1:350), rabbit anti-PABP (1:500), mouse anti-Islet 1 (DSHB,
Iowa City, IA, http://www.uiowa.edu/~dshbwww, 1:200),
mouse or rabbit anti-Tuj1 (Covance, Princeton, NJ, http://
www.covance.com, 1:1,000), mouse anti-p62 (Abcam, Cam-
bridge, U.K., http://www.abcam.com, 1:500), rabbit anti-GA
(ProteinTech, 1:500), rabbit anti-GP (ProteinTech, 1:500), rab-
bit anti-PR (ProteinTech, 1:500), rabbit anti-GR (ProteinTech,
1:500), goat anti-TIA-1 (Santa Cruz Biotechnology, Santa Cruz,
CA, http://www.scbt.com, 1:500). After washing with 0.1% Tri-
ton-X/PBS three times for 10 minutes, the samples were incu-
bated with Alexa Fluor 488 or Alexa Fluor 568 conjugated
goat anti-rabbit or goat anti-mouse secondary antibodies (Life
Technologies) for 1 hour at room temperature. Nuclei were
stained with 4’,6-Diamidino-2-Phenylindole (DAPI). Fluores-
cence was visualized using a confocal microscope Zeiss LSM.
Immunoblotting
Cells were washed with PBS and then scraped in PBS. Cells
were lysed in RIPA buffer (0.5% sodium deoxycholate, 0.1%
SDS, 1% Nonidet P40 and 1% protease inhibitor cocktail
(Sigma)), sonicated, and incubated on ice for 30 minutes.
After centrifugation at 5,000g for 10 minutes, the supernatant
was retained, and protein concentration was quantified using
the BCA assay according to the manufacturer’s instructions
(Sigma). Protein was boiled in Laemmli buffer for 5 minutes
at 958C, and 10 lg of protein were loaded on gels. For West-
ern blot analysis, lysates were resolved on a SDS-PAGE (10%
or 12% Tris-glycine gel) using a Novex X-Cell electrophoresis
system (Life Technologies) under constant current (125 mA for
1 hour) and transferred to a methanol activated polyvinyli-
dene difluoride membrane (Immobilon-P) using the Novex
Blot system under constant voltage (100 mA for 90 minutes).
Blots were blocked in blocking buffer (PBS, 1% Tween-20, 5%
skimmed milk) for 1 hour at room temperature and then incu-
bated in PBS11%Tween-201 1% milk with primary antibodies
overnight at 48C. Primary antibodies used were mouse anti-
Bcl-2 (Dako, Glostrup, Denmark, http://www.dako.com, 1:200),
mouse anti-SQST1/p62 (Abcam, 1:1,000), rabbit anti-GRP78/
BiP (Abcam, 1:1,000), mouse anti-b-actin (Sigma, 1:5,000).
Horseradish peroxidase (HRP)-conjugated anti-mouse IgG or
anti-rabbit IgG (BioRad, Hercules, CA, http://www.bio-rad.
com) were used as secondary antibodies, and the signal was
visualized using an ECL or ECL Plus detection system (Amer-
sham Pharmacia Biotech, Piscataway, NJ, http://www.amer-
sham.com). The integrated optical density of each band was
measured in ImageJ, and expression was normalized to actin
levels in the same blot for comparative expression
assessment.
For dot blot analysis, a strip of nitrocellulose membrane
was used, and 10 mL containing 10 mg of protein were loaded
as a dot. The blot was allowed to dry and blocked in 5% skim
milk 0.1% Tween/PBS for 1 hour. The blocking buffer was
removed and primary antibodies were added to each dot
(1:1,000) and incubated for 1 hour at room temperature. The
membrane was washed three times for 10 minutes, and HRP-
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conjugated anti-rabbit secondary antibodies were added for 1
hour at room temperature. The membrane was washed three
times for 10 minutes in 0.1% Tween/PBS and the signal was
detected by ECL (Amersham Pharmacia Biotech).
Propidium Iodide Staining
Propidium iodide (PI) staining was performed according to the
manufacturer’s instructions (Sigma). Briefly, the neurons were
incubated with 1 mg/mL PI stock solution and RNase A for 10
minutes at 378C. The solution was then washed with PBS, and
cells were fixed in 4% PFA. Immunocytochemistry was then
performed as described above.
Mitochondrial Staining
Cultures of differentiated MNs were incubated with 100 nM
of the potentiometric dye MitoTracker Red CMXRos (Thermo
Fisher) for 45 minutes at 378C. The neurons were then
washed with PBS, fixed in 4% PFA, and immunostained for
Islet1 and SMI-32 according to the immunocytochemistry pro-
tocol above.
ER Calcium Imaging
Mature MNs were loaded with 10 lM Fluo-4 AM dissolved in
0.2% dimethyl sulfoxide (Sigma-Aldrich, St. Louis, http://www.
sigmaaldrich.com) with 0.04% Pluronic acid in Hank’s Balanced
Salts Solution (HBSS) supplemented with CaCl2 and MgCl2. To
image Ca21 signals, we used wide-field fluorescence micros-
copy using a Nikon TE 2000 inverted microscope equipped
with a 340 oil-immersion objective and EMCCD camera
(Evolve 128, Photometrics) for imaging fluorescence emission
(510–600 nm) at a frame rate of 300 s21. Fluorescence was
imaged at 258C from a 12 3 12 mm (128 3 128 pixel) region
within 18 mm coverslips, on which MNs were cultured. ER
Ca21 concentration levels were assessed by fluorescence
measurements upon application of 1 mM thapsigargin (Life
Technologies) in HBSS depleted of CaCl2 and MgCl2. Fluores-
cence measurements are expressed as a ratio (DF/F0) of the
mean change in fluorescence (DF) at a pixel relative to the
resting fluorescence at that pixel before stimulation (F0).
Image analysis was performed using MetaMorph and ImageJ
software.
RNA Fluorescence In Situ Hybridization (FISH)
Cells grown on 12 mm RNase-free coverslips in 24-well plates
were fixed using 4% PFA for 20 minutes, washed in PBS, and
permeabilized using 0.2% Triton X-100 (Sigma) in PBS for 30
minutes. Cells were then dehydrated in a graded series of
alcohols, air dried, and rehydrated in PBS, briefly washed in
23 standard sodium citrate (SSC) and then incubated in pre-
hybridization solution and hybridization solution as previously
described using Cy3-conjugated 20O-methyl RNA probes (Inte-
grated DNA Technologies) [35]. Probe sequences were
(CCCCGG)4 or (CAGG)6. Optional treatments using RNase
(0.1 mg/mL; Life Technologies) or DNase (150 U/mL, Qiagen)
were performed at 378C for 1 hour following permeabilization.
Following hybridization washes, staining with Tuj1 (1:2000,
Covance) and Islet1 (1:200, DSHB) were performed as
described above.
Electrophysiology
A coverslip containing iPSC-derived MNs was placed in a
recording chamber mounted onto the stage of an upright
microscope and the somata were targeted for recording using
IR-DIC optics. Cells were continuously superfused with oxy-
genated artificial cerebrospinal fluid aCSF (95% O2/5% CO2)
containing 130 mM NaCl, 25 mM NaHCO3, 2.5 mM KCl,
1.25 mM NaH2PO4, 2 mM CaCl2, 2 mM MgCl2, and 10 mM
glucose. Patch-clamp electrodes (4–7 MX) were filled with an
intracellular solution containing 120 mM K-gluconate, 10 mM
KCl, 10 mM HEPES, 4 mM MgATP, 0.3 mM NaGTP, 10 mM Na-
phosphocreatine. Recordings were obtained using a Multi-
clamp 700B amplifier and digitized at 10–20 kHz using Digi-
data 1550 acquisition board.
Southern Blotting
5 mg of DNA were digested with 2 mL each of FastDigest DdeI
and FastDigest AluI (Thermo Scientific) for 2 hours at 378C.
Digested DNA underwent electrophoresis in 0.8% agarose gel
in 31 Tris-acetate-EDTA (TAE) and was transferred to a posi-
tively charged nylon membrane (Roche, Basel, Switzerland,
http://www.roche-applied-science.com) by capillary blotting.
Roche digoxigenin (DIG)-labeled DNA molecular weight marker
II was used as a ladder. DNA was crosslinked to the mem-
brane by UV irradiation. Prehybridization was carried out in
20 mL DIG Easy Hyb solution (Roche) at 538C for 2 hours. 10
ng DIG-labeled (GGGGCC)5 probe (custom synthesized by Inte-
grated DNA Technologies) was incubated at 958C for 5
minutes, snap cooled on ice for 30 seconds, and immediately
added to 7 mL DIG Easy Hyb solution prewarmed to 608C.
Hybridization took place overnight at 538C. Stringency washes
were performed at 648C as follows: 23 SSC, 0.1% sodium
dodecyl sulphate (SDS) for 5 minutes, 23 SSC, 0.1% SDS for
10 minutes, 13 SSC, 0.1% SDS for 15 minutes three times,
0.53 SSC, 0.1% SDS for 15 minutes twice.
The membrane was prepared for detection using the DIG
Wash and Block buffer set (Roche). The membrane was
washed with wash buffer for 2 minutes then incubated with
blocking solution for 1–2 hours. Anti-DIG-AP Fab fragments
(Roche) were incubated with the membrane at room temper-
ature for 20–25 minutes at 1 in 10,000 dilution in blocking
solution. Three washes were carried out for 5, 15, and 15
minutes followed by a 5-minute equilibration step using the
supplied Detection buffer. CDP-Star (Roche) was added to the
membrane for at least 5 minutes, and signal was detected by
exposure to x-ray film. Repeat number was estimated by
interpolating a plot of log10 of band size in base pairs versus
distance travelled on the blot, with subtraction of 199 bp
from the estimated base-pair number to account for the wild-
type allele as performed by Beck et al. [36].
Table 1. Oligos used for quantitative reverse transcriptase poly-
merase chain reaction
Oligo Sequence
BAK_fwd 50-GGGTCTATGTTCCCCAGGAT-30
BAK_rev 50-GCAGGGGTAGAGTTGAGCA-30
Bcl-XL_fwd 50-ATGAACTCTTCCGGGATGG-30
Bcl-XL_rev 50-TGGACTCAAGGCTCTAGGTG-30
BIM_fwd 50-GGTCCTCCAGTGGGTATTTCTCTT-30
BIM_rev 50-ACTGAGATAGTGGTTGAAGGCCTGG-30
HPRT_fwd 50-GCTATAAATTCTTTGCTGACCTGCTG-30
HPRT_rev 50-AATTACTTTTATGTCCCCTGTTGACTGG-30
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qRT-PCR
RNA was isolated from iPSC-derived MNs using the Qiagen
RNeasy kit, according to the manufacturer’s instructions. 500
mg of total RNA was used for reverse transcription reaction
using SuperScript III reverse transcriptase (Life Technologies).
Quantitative real-time PCR was performed with 100 mg of
RNA reverse transcribed to cDNA and SYBR Green qPCR
Supermix (Roche). Primers used for qPCR are listed below in
Table 1.
Repeat-Primed PCR
Repeat-primed PCR (RP-PCR) assay was performed as previ-
ously described [1], in a reaction volume of 15 lL, containing
100 ng genomic DNA, 8 lL Extensor mastermix (Thermo Sci-
entific), 6 lL of 5 M Betaine, 20 lM of both forward and
repeat specific primer and 2 lM of reverse primer. The reac-
tions were subjected to touchdown PCR programme, then 1
lL of each PCR product was mixed with 8 lL of Formamide,
and 0.5 lL GeneScan size standard (Applied Biosystem, Foster
City, CA, http://www.appliedbiosystems.com). Then samples
were analyzed on an ABI3730 DNA Analyzer and visualized
using GeneMapper software. Primer sequences used: RP1-F
FAM-TGTAAAACGACGGCCAGTCAAGGAGGGAAACAACCGCAGCC;
RP1-R CAGGAAACAGCTATGACC; RP1-Repeat: CAGGAAACA
GCTATGACCGGGCCCGCCCCGACCACGCCCCGGCCCCGGCCCCGG.
Electron Microscopy
Cells grown on polyester filters were immersion fixed with
2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.2) for
10 minutes at room temperature and prepared for electron
microscopy (EM) by standard methods. Briefly, filters were
stained with osmium tetroxide (1% v/v in 0.1 M phosphate
buffer) and uranyl acetate (2% w/v in distilled water), dehy-
drated through increasing concentrations of ethanol (70%–
100%) and acetone and embedded in Spurr’s resin (Agar sci-
entific, Reading, U.K.). Ultrathin sections (50–80 nm) were
prepared by use of a Reichart-Jung ultracut microtome and
mounted on nickel grids (Agar Scientific, Stanstead, Essex,
U.K.). Sections were counterstained with lead citrate and ura-
nyl acetate and examined on a JOEL 1010 transmission elec-
tron microscope (JOEL USA, Peabody, MA).
Statistical Analyses
All quantitative data were analyzed using GraphPad Prism.
Groups of three or more samples were subject to one-way
Figure 1. iPSC line characterization. Characterization data for line iPS C9 T2 7. (A): Karyogram showing genome integrity of iPSC (Illu-
mina SNP array data analyzed using Karyostudio). Autosomal detected regions deviating from reference data are annotated with green
(amplification) or orange bands (deletion); the left hand panel shows the parental fibroblasts as reference. (B): FACS analysis of iPSC for
pluripotency markers Tra-1-60 and Nanog (black line); grey filled plot, isotype control. (C): Human iPSC show pluripotent stem cell-like
morphology (cell-cell-contact-dependent clusters, with high nucleus to cytoplasm ratio) by phase microscopy; scale bar5 100 mm. (D):
PluriTest analysis of Illumina HT12v4 transcriptome array data shows that all the iPSC lines used cluster with pluripotent stem cells (red
cloud) and not with partly- or differentiated cells (blue clouds). Each circle represents one iPSC line, with previously published lines
OX1-19 and NHDF-1 included as reference points [15AH017-13; 25OX3-9; 35OX1-61; 45 C902-10; 55AH017-3; 65OX1-19;
75NHDF-1; 85 7245-1; 95 7245-3; 105 T2-7; 115 C902-02; 125 T2-6]; y axis pluripotency score, x axis novelty score. (E): Assess-
ment of Sendai clearance from iPSC lines reprogrammed with SeVdp(KOSM)302L, by qRT-PCR, relative to positive control. Abbreviations:
iPSC, induced pluripotent stem cell; qPCR, quantitative polymerase chain reaction
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ANOVA, with Bonferroni or Dunnett’s post hoc comparisons.
Alpha was set at 0.05 for all ANOVAs and post hoc tests.
Dataset Deposit
The Illumina HT12v4 transcriptome array results have been
deposited in the GEO under accession number GSE64583. SNP
datasets have been deposited in GEO under the accession
number GSE64582. These are both contained in the Supers-
eries GSE64584.
RESULTS
Reprogramming of Patient Fibroblasts to Generate
iPSCs
Two lines from each of three patients (C9-T2, C9-7245, C9-02)
were generated, along with lines from control donors. Figure 1
shows the representative characterization data for one of the
patient iPSC lines generated for this study, iPSC C9-T2-7 (data
for the other previously unpublished iPSC lines, including control
lines, is given in Supporting Information Fig. S1). SNP analysis
confirmed the identity of the iPSC in relation to their parental
fibroblasts and that they had not acquired large-scale copy num-
ber variations, although a small number of small-scale indels
(well below the level that would be detected by G-banding)
were noted, particularly in the C9-7245 lines (Fig. 1A; Supporting
Information Fig. S1A). SNP datasets for these lines have been
deposited in GEO under the accession number GSE64582.iPSC
lines were positive for pluripotency markers (TRA-1-60 and
Nanog, Fig. 1B; also Supporting Information Fig. S1B) and
showed human pluripotent stem cell-like morphology (cell-cell-
contact-dependent clusters, with high nucleus to cytoplasm ratio,
Fig. 1C; Supporting Information Fig. S1C). PluriTest is a quantita-
tive assessment of pluripotency based on transcriptome data
from iPSCs in comparison to a large reference set of genome-
wide profiles from multiple cell and tissue types. It measures a
“pluripotency score” (expression of pluripotency genes, with
high scores correlating with high pluripotency, y-axis) and a
“novelty” score (expression of nonpluripotent stem cell genes,
therefore this score inversely correlates with pluripotency, x-
axis). All the patient iPSC lines were deemed to be fully reprog-
rammed and pluripotent by this analysis (Fig. 1D). The Illumina
HT12v4 transcriptome array results have been deposited in the
GEO under accession number GSE64583. Finally, all banked iPSC
line stocks had undetectable levels of residual Sendai virus RNA
by qRT-PCR (Fig. 1E; Supporting Information Fig. S1D).
C9orf72 iPSCs Differentiate to Functional MNs
In vitro cell differentiation protocols recapitulate signaling
events that occur during embryogenesis. The differentiation of
iPSCs to spinal MNs is a three-stage process that involves
neuralization, caudalization, and ventralization. The iPSC lines
were differentiated to MNs according to three previously pub-
lished protocols, with some modifications [29, 30, 33] (Sup-
porting Information Fig. S2A–S2C).
The fully differentiated MNs were identified by immuno-
staining with the MN marker HB9 and neuronal marker b-III
tubulin (Tuj1), which indicated successful differentiation of
iPSCs to MNs (Supporting Information Fig S2D). The iPSC-
derived MNs showed expression of synaptophysin, a synaptic
vesicle protein essential for the formation of synapses, as well
as the expression of choline acetyltransferase, which demon-
strates an advanced degree of cholinergic neuron maturation
(Supporting Information Fig S2D, S2E).
Two iPSC lines were reprogrammed from each patient’s
fibroblasts and differentiated to MNs for characterization. To
assess differentiation efficiency, MNs positive for Islet1/Tuj1
were counted in control lines AH017-13, OX3-9, OX1-19, and in
C9orf72 patient lines C9-T2-6, C9-T2-7, C9-7245-1, C9-7245-3,
C902-2, and C902-10 (Fig. 2A). Differentiation efficiency was
assessed after 8 weeks of neural culture, with a highly neural-
ized population indicated by a mean of 82% of Tuj1-positive
cells across all lines (Fig. 2B). Approximately half of the Tuj1-
positive neural cells in these cultures were also positive for the
postmitotic MN marker Islet1 (42.7%–46.4% of total cells) (Fig.
2C). CNs were differentiated in parallel, and functional experi-
ments were carried out after 70–100 days in culture [34] (Sup-
porting Information Fig. S2E). The sizes of the expansions were
determined by Southern blotting in the mature MNs and esti-
mated at 510–690 repeats for C9-T2-6, 420–640 repeats for C9-
T2-7, 1,210 for C9-7245-1, 1,380 for C9-7245-3, 1,000 for C902
(Supporting Information Fig. S3A). The presence of the repeats
was also confirmed by RP-PCR in C9-02-2 and C9-7245-3 MNs
and the absence of repeats was confirmed in the control lines
OX1-19 and AH017-13 (Supporting Information Fig. S3B).
To assess the functional maturation of the iPSC-derived
MNs, we performed whole-cell patch clamp recordings to
determine their electrophysiological properties. Trains of
action potentials were elicited in both control and patient
MNs in response to depolarizing current injection in current-
clamp recordings (Fig. 2D, 2E). Inward and outward ionic cur-
rents were recorded by voltage clamp in both controls and
patients (Fig. 2F, 2G). Ca21 dynamics were investigated using
the calcium-sensitive dye Fluo-4 AM. In the absence of exter-
nal stimulation, spontaneous calcium transients were detecta-
ble in the cell bodies and processes of the neurons (Fig. 2H).
The neurons were then stimulated with kainate (KA), to acti-
vate ionotropic receptors, and with KCl to depolarize the
membrane and activate voltage-gated Ca21 channels. Expo-
sure to KCl induced Ca21 transients in Islet11 MNs (Fig. 2I).
Similarly, exposure to KA induced characteristic increases in
intracellular Ca21 levels in 80% of the cells (Fig. 2J).
RNA Foci and RAN Dipeptides are Present in
C9orf72 MNs
In the MNs derived from C9orf72 patients, we identified a sig-
nificant increase in intranuclear GGGGCC-repeat containing
RNA foci in all lines (Fig. 3A, 3B). The specificity of the probe
was confirmed by treatment with RNase, which reduced the
number of foci substantially (Supporting Information Fig. S4A),
and with DNase I, after which the number of foci was main-
tained. To investigate evidence for the RAN translation
hypothesis, we performed a dot blot analysis using anti-GA,
GP, GR, and PR antibodies, and we could detect traces of all
the dipeptides in the MNs from C9orf72 patients (Fig. 3C).
Elevated ER Ca21 Levels, Altered Mitochondrial
Morphology, and Reduced Bcl-2 Levels in C9orf72 MNs
Although a direct link between calcium signaling and C9orf72
expansions has not yet been reported, calcium dysregulation is
an established feature of the pathogenesis of ALS. The levels of
Ca21 stores in the ER were analyzed in fully differentiated MNs
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from eight separate cultures of three independent differentia-
tions for each cell line (OX3-9, C9-T2-6, C9-T2-7, C9-7245-1,
and C9-7245-3). To assess the total content of ER Ca21 stores,
10 lM thapsigargin (TG) was applied to the MNs, and the peak
increase in fluorescence intensity resulting from ER Ca21 deple-
tion into the cytoplasm was measured (Fig. 4A, 4B). TG acts as
a potent inhibitor of the SERCA pump on the ER membrane,
blocking the reuptake of Ca21 ions from the cytoplasm. In our
cultures, we detected significantly higher levels of ER Ca21 con-
tent in the C9orf72 iPSC-derived MNs, which showed up to
twofold increase in cytoplasmic fluorescence intensity com-
pared to the control MNs (p< .05, one-way ANOVA) (Fig. 4C).
Abnormal elevations in ER Ca21 levels can cause ER stress
and can activate the UPR. We investigated levels of proteins
associated with the UPR and ER stress responses, and we
found significantly elevated levels of GRP78/BiP in C9-7245-1
and C9-7245-3 iPSC-derived MNs compared to AH017-13 and
OX1-61 MNs (p< .05, one-way ANOVA) (Fig. 4D, 4E). We did
not detect differences in the splicing of XBP-1 between
patients and controls (Supporting Information Fig. S5A).
The Bcl-2 family of proteins are key components involved
in the modulation of calcium homeostasis in the ER, controlling
the release of Ca21 ions through the IP3R and through chan-
nels formed by its own dimerization [19]. The balance between
proapoptotic and antiapoptotic members of the Bcl-2 family is
essential for controlling ER stress-induced apoptosis and mito-
chondrial membrane permeability [17]. In C9orf72 MNs, we
detected an imbalance between proapoptotic and antiapoptotic
members of the Bcl-2 family, which showed up to 50% down-
regulation of antiapoptotic Bcl-2 in C9-7245-1, C9-7245-3, and
Figure 2. Functional characterization of C9orf72 induced pluripotent stem cell (iPSC)-derived MNs. (A): Immunostaining for Islet1 and
Tuj1 in control lines (OX1-19, OX3-9, AH017) and six patient lines (C9-T2-6, C9-T2-7, C9-7245-1, C9-7245-3, C902-2, C902-10). (B): Quanti-
fication of Tuj1 positive cells shows 80%–95% of cells are neuronal and (C) quantification of Islet1 positive cells shows 23%–40% of cells
are motor neurons, with nonsignificant differences between the genotypes (*, p> .05, one-way ANOVA). (D): Whole cell recording
reveals that trains of action potentials can be evoked reliably in both control MNs and (E) C9orf72 MNs. Representative voltage clamp
data showing inward and outward currents recorded during step membrane depolarization of control OX3-9 (F) and C9-7245-3 (G) neu-
rons. (H): Spontaneous calcium oscillations were recorded from neurons after incubation with Fluo-4 AM, and typical elevations in intra-
cellular calcium were detected on stimulation with (I) KCl and (H) kainate (control neurons are shown in this image). n5 3 independent
differentiations; m 510–15 neurons recorded per line; 5 neurons per line for ionic current measurements. Data are represented as
average6 SEM. Scale bar5 20 mm. Abbreviations: DAPI, 40,6-Diamidino-2-Phenylindole; MNs, motor neurons.
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C902-2 patient lines (Fig. 4F, 4G) and 75% reduction of Bcl-XL
(p< .05, one-way ANOVA) (Fig. 4H). Significant upregulation of
proapoptotic BAK was detected in the MNs with large expan-
sions, which showed up to 2.5-fold increase in expression
(p< .05, one-way ANOVA) (Fig. 4I). A significant upregulation
of the proapoptotic BIM was also detected in some of the MN
lines (Supporting Information Fig. S5B).
The Bcl-2 family of proteins is distributed throughout the
ER and mitochondrial membranes, where they play critical
roles in regulating intracellular Ca21 homeostasis and
exchange of Ca21 between the two organelles. Following dys-
function of these proteins and Ca21 overload, the mitochon-
dria undergo typical morphological changes, such as swelling
and perturbation of the outer membrane, accompanied by
the release of apoptotic factors [37]. To assess these altera-
tions, we used the potentiometric dye MitoTracker Red
CMXRos, accumulation of which is dependent on mitochon-
drial potential (Fig. 4J). We found up to 30% reduction in
mitochondrial membrane potential in C9 MNs compared to
controls (p< .01, one-way ANOVA) (Fig. 4K).
In line with these findings, analysis of morphological alter-
ations of the mitochondria using EM also revealed swollen
mitochondria in the neurons from C9orf72 patients compared
to the healthy control (Fig. 4L). Alterations of the mitochon-
drial morphology and abnormalities in the cristae structures
were observed in up to 88% of C9orf72 neurons compared to
only 2% normal healthy neurons (Fig. 4M).
These mitochondrial alterations are consistent with the
release of apoptotic factors, such as cytochrome c, which was
found to be elevated in all patient lines, specifically in the C9-
7245-1 compared to healthy controls (p< .05, one-way
ANOVA) (Fig. 4N, 4O). These results indicate an association
between C9orf72 expansions and elevated ER Ca21 concentra-
tions and stress, as well as mitochondrial alterations which
may be the drivers for downstream apoptosis.
C9orf72 iPSC-Derived MNs and CNs have Increased
Susceptibility to Apoptosis
To investigate whether MNs and CNs carrying pathogenic
hexanucleotide expansions in C9orf72 develop an apoptotic
Figure 3. RNA foci and repeat-associated non-ATG dipeptides are detected in C9orf72 patient-derived motor neurons (MNs). (A):
[CCCCGG]4 probe was used to detect sense RNA foci from the C9orf72 hexanucleotide expansions. (B): RNA foci were detected in up to
65% of neurons from C9orf72 induced pluripotent stem cell (iPSC)-derived MNs (121–157 neurons counted), while no foci were
detected in the controls (**, p< .01, one-way ANOVA). (C): Dot blot analysis of GR, PR, GA, and GP dipeptides in controls (OX3-9 and
AH017) and patient lines (C902-2, C9-7245-3 and C902-3) at baseline and after treatment with MG-132 for 24 hours. Scale bar5 5 mm.
Data are represented as average6 SEM. Abbreviation: DAPI, 40,6-diamidino-2-phenylindole.
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Figure 4. Increased ER Ca21 content is detected in C9orf72 induced pluripotent stem cell (iPSC)-derived MNs along with mitochondrial
alterations and Bcl-2 protein imbalance. (A): Images representing the iPSC-derived neurons before and after TG stimulation and (B) their
representative fluorescent traces. (C): Measurement of the TG-evoked ER Ca21 release shows significantly higher ER Ca21 levels in C9-
T2 and C9-7245 lines compared to OX3-9 (***, p< .001; *, p< .05; one-way ANOVA with Dunnet’s post hoc test); n5 3 independent
differentiations, m5 150–200 neurons recorded per genotype. (D): Immunoblotting shows elevated levels of GRP78/BiP in all patient
lines and significantly upregulated in C9-7245-1 and C9-7245-3 (*, p< .05, one-way ANOVA with Dunnet’s post hoc test) (E). n5 3 inde-
pendent differentiations, m5 142–200 neurons recorded per genotype per differentiation. (F): Immunoblotting for the antiapoptotic
Bcl-2 protein shows downregulation of levels in patient lines and (G) significant reduction in C9-7245-1 and C9-7245-3 and C902-2 com-
pared to control OX3-9, AH017-13, and OX1-61 (*, p< .05; **, p< .01, one-way ANOVA with Dunnett’s post hoc test); n5 3 independ-
ent differentiations (n5 2 independent differentiations for AH017-13 and OX1-61), m5 3–4 technical replicates. (H): Quantitative
polymerase chain reaction confirms downregulation of Bcl-XL and upregulation of (I) BAK, specifically in the C9-7245 and C902-2 MN
lines (*, p< .05; **, p< .01; ***, p< .001, one-way ANOVA with Dunnett’s post hoc test); n5 2 independent differentiations; m5 3
technical replicates. (J): Representative image of OX3-9 loaded with MitoTracker Red CMXRos and immunostained with Islet1 and Tuj1.
(K): Quantification of the mean fluorescence intensity of MitoTracker in Islet11/Tuj11 neurons shows reduced mitochondrial membrane
potential in all patient lines (***, p< .001, one-way ANOVA with Dunnett’s post hoc test); n5 2 independent differentiations; m5 17–
31 neurons analyzed per genotype. (L): Electron micrographs (EM) show enlarged mitochondria and christae in the patient lines C902-2
and C9-7245-3 compared to a healthy control (OX3-9). Arrows point to mitochondria. (M): Quantification of EM images for mitochon-
drial alterations show 88% of C9orf72 neurons with swollen mitochondria (**, p< .01, ANOVA with Dunnet’s post hoc test). (N): Cyto-
chrome c levels are elevated in all patient lines and significantly higher than healthy controls in C9-7245-1 (*, p< .05, one-way ANOVA
with Dunnett’s post hoc test). n5 2 independent differentiations, m5 2 technical replicates each. (O): CNs show elevated levels of the
apoptotic marker cytochrome c in C902-10 (*, p< .05; **, p< .01, one-way ANOVA with Dunnett’s post hoc test). n5 2 independent
differentiations. Scale bars5 20 mm (J), 1 mm (L). Data are represented as average6 SEM. Abbreviations: CNs, cortical neurons; ER,
endoplasmic reticulum; MNs, motor neurons; TG, thapsigargin.
phenotype under normal culture conditions, we assessed
markers of cellular stress and cell death. Caspases are pres-
ent in the cell as inactive proenzymes which can be
activated by proteolytic cleavage, the cleavage of caspase-3
being an essential process that initiates the apoptotic disas-
sembly of the cell. In neurons from C9orf72 patients we
Figure 5. Cleaved caspase-3 is frequently detected in C9orf72 MNs and cortical neurons (CNs) and reduced cell viability is found in
C9orf72 MNs and CNs. (A, B): Immunostaining for cleaved caspase-3 shows increased frequency of apoptotic neurons in C9orf72 MNs
compared to control MNs (*, p< .05; **, p < .01, one-way ANOVA with Dunnett’s post hoc test); n5 3 independent differentiations;
m5 400 cells per genotype analyzed for each individual experiment. (C): Reduced cell viability was detected in C9orf72 MNs by PI stain-
ing (***, p< .001, one-way ANOVA with Dunnett’s post hoc test) n5 2 independent differentiations. (D, E): Immunostaining with
cleaved caspase-3 shows significantly increased frequency of positive cortical neurons in C902-2 and C902-10 lines compared to two
healthy control lines (OX3-9 and AH017-13) (*, p< .05; ***, p< .001, one-way ANOVA with Dunnett’s post hoc test). (F): Reduced viabil-
ity was detected by PI staining in the C9orf72 patient (***p< .001, one-way ANOVA with Dunnett’s post hoc test). n5 3 independent
differentiations. Data are represented as average6 SEM. Scale bar5 20 mm. Abbreviations: MNs, motor neurons; PI, propidium iodide.
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found significantly increased immunostaining for cleaved
caspase-3 compared to the CNs from OX1-19, OX3-9, and
AH017-13 (Fig. 5A). We detected between 8.1% and 10.5%
of neurons positive for cleaved caspase-3 in the C9orf72
patient lines, compared to a maximum of 2.9% in OX1-19 and
1.9% in OX3-9 (p< .05, one-way ANOVA) (Fig. 5B). In line with
this finding, the ALS/FTD-derived MNs also showed significantly
increased staining with PI in up to 32% of C9orf72 MNs com-
pared to healthy MNs, indicating reduced survival compared to
control MNs (p< .01, one-way ANOVA) (Fig. 5C).
In CN cultures, we found a significantly high frequency of
cleaved caspase-3 in the C902-2 and C902-10 lines, with up to
35% of neurons positive for apoptotic markers compared to
controls (p< .05, one-way ANOVA) (Fig. 5D, 5E). These results
also correlated with high PI staining, which was found in up
to 40% of the neurons analyzed in the C902 patient lines
(p< .001, Student’s t test) (Fig. 5F). Taken together, these
results demonstrate that the presence of the C9orf72 hexanu-
cleotide expansions activates caspase-3 dependent apoptosis
in both MNs and CNs of patients.
Stress Granules and Protein Aggregates are Present in
C9orf72 iPSC-Derived MNs and CNs
SQST1/p62, a marker of the UPR and autophagy flux is found
in neuronal aggregates in autopsy samples from C9orf72 ALS/
FTD cases. We found significantly elevated levels of SQST1/
p62 in MNs derived from each C9orf72 patient, and the
patient with the highest number of repeats showed up to
twofold higher expression of SQST1/p62 compared to control
MNs at baseline (p< .05, one-way ANOVA) (Fig. 6A–6C). No
differences were detected in the autophagic marker LC3-II/
LC3-I in MNs (Supporting Information Fig. S5C, S5D). In CNs
carrying the C9orf72 expansions we also found approximately
40% neurons positive for p62 aggregates (Fig. 6D–6F). In con-
trast to MNs, these results correlated with an increase in lev-
els of LC3-II in C902-2 and C902-10 compared to controls
OX3-9 and AH017-13 (p< .05, one-way ANOVA) (Fig. 6G).
Stress granules are formed when RNA binding proteins
aggregate through their glycine rich domains. These granules
function to sequester, silence, or degrade specific RNA tran-
scripts as part of a mechanism that adapts patterns of local
RNA translation to facilitate the response to cellular stress
[38]. PABP is a major component of stress granules and
serves as a robust marker of the activation of the stress
response. In our neuronal culture, we found up to fivefold
increase in the frequency of neurons with PABP-positive
granules under resting conditions in all five C9orf72 patient
MN lines compared to controls (p< .05, one-way ANOVA)
(Fig. 6H, 6I). The C9orf72 MNs were also immunopositive
for the early stress granule marker, TIA-1 (Fig. 6H). PABP
positive stress granules were detected in up to 40% of
C9orf72 CNs compared to a maximum of 20% control CNs
(Fig. 6J, 6K).
DISCUSSION
The inability to directly study neurons in patients suffering
from neurodegenerative disorders has been a significant
impediment to the understanding of basic mechanisms,
particularly those occurring early in the disease process.
Recent developments in stem cell technology have sub-
stantially expanded the range of cellular models available
in ALS by allowing the direct observation of pathomechan-
isms in MNs derived from iPSC obtained from fibroblasts
harboring the genetic background conferring disease
susceptibility.
The mechanisms underlying C9orf72 toxicity in MNs
remain to be elucidated, but possibilities include haploinsuffi-
ciency and toxic gain-of-function, mediated either by RNA foci
or toxic aggregation-prone polypeptides resulting from RAN
translation [1, 10, 39, 40]. These potential mechanisms are
not mutually exclusive and may each play a role. In this study,
we identified several converging pathways that are altered in
MNs and CNs from C9orf72 patients.
RNA foci have been consistently detected in the CNs of
patients with hexanucleotide repeats [1, 14], and we detected
discrete RNA foci in our MN cultures from all C9orf72 patient
lines. Since the presence and number of RNA foci did not cor-
relate with other phenotypes, the relationship of RNA foci to
the pathology we observe in this cellular model requires fur-
ther investigation. A dot blot analysis using high levels of pro-
teins revealed the presence of the GA, GP, GR, and PR
dipeptides in the patient lines, but given their low abundance
and difficulty of detection, it is challenging to analyze their
contribution to neuronal degeneration in our cellular model.
A recent study has shown the formation of stress granules in
neuronal cells transfected with poly-GA, poly-GP, and poly-PA,
suggesting that RAN translation may be associated with stress
granule formation and neurodegeneration [41]. In our cultures
of C9orf72 MNs and CNs, we detected the frequent presence
of stress granules under baseline conditions. Stress granules
are conserved cytoplasmic aggregates of nontranslating mes-
senger ribonucleoprotein complexes, and they are dynamic
structures which dissociate when conditions return to normal
or they are cleared by autophagy [42]. The accumulation of
PABP1 stress granules suggests impairments in autophagy and
proteasomal degradation, and the convergence of these two
dysfunctional pathways may partially explain the vulnerability
of C9orf72 MNs and CNs to degeneration.
Calcium is known to exert a complex regulatory role in
the ER-mitochondrial crosstalk, playing an essential part in
cell death signaling [43]. Bcl-2 together with Bcl-XL are
located on the ER membrane where they lower the [Ca21]ER
by forming Ca21 permeable leakage pores [44]. Reduced lev-
els of Bcl-2 and Bcl-XL contribute to nonphysiological accu-
mulation of Ca21 ions into the ER due to reduced leakage,
and we confirmed elevated levels of ER Ca21 stores in the
C9orf72 MNs. We have recently shown that TDP-43 patho-
genic mutations in mouse MNs and in a human cellular
model also interfere with ER Ca21, but with the opposite
effect, showing reduced ER Ca21 levels and decreased ER
Ca21 release [45].
The tight connection between the ER Ca21 stores and
mitochondria allows cells to respond promptly and efficiently
to various Ca21 stimuli. However, under pathological condi-
tions, the high levels of Ca21 from the ER will overload the
mitochondria and consequently induce mitochondrial swel-
ling, rupture of the outer membrane, and release of apopto-
tic factors from the mitochondria [37]. The antiapoptotic
protein Bcl-2 is located on the mitochondrial membrane
where it prevents proapoptotic BAK/BAX to oligomerize and
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to form channels that allow release of the apoptotic factor
cytochrome c into the cytosol. Low levels of Bcl-2 and
increased levels of BAK promote the release of cytochrome c
from the mitochondria triggering the activation of caspases
that regulate the induction and execution of apoptosis [46].
Consistent with this, we detected high levels of cleaved
Figure 6. p62 is elevated in C9orf72 neurons and PABP immunopositive stress granules form spontaneously in C9orf72 neurons. (A): Immu-
nostaining for p62 in C9 motor neurons (MNs) shows aggregates are formed under baseline conditions. (B, C): Immunoblotting demonstrates
high levels of p62 in C9-T2-6, C9-7245-3, and C902-2 MNs compared to controls under baseline conditions (*, p< .05; **, p< .01, one-way
ANOVA with Dunnet’s post hoc test); n5 2 independent differentiations, m5 3 technical replicates. (D, E): p62 aggregates are detected
more frequently in C9 CNs compared to controls (***, p< .001, one-way ANOVA with Dunnett’s post hoc test). (F, G): Immunoblotting shows
elevated levels of LC3-II in both lines from the C9orf72 patient C902 compared to controls (***, p< .001, one-way ANOVA with Dunnett’s
post hoc test); (H) PABP1 and TIA-11 stress granules are detected in all five C9 patient lines under baseline conditions and (I) PABP1MNs are
significantly more frequent than in controls (*, p< .05; ***, p< .01, one-way ANOVA with Dunnet’s post hoc test); n5 3 independent differ-
entiations; m5 387–918 neurons analyzed per genotype. (J, K): PABP1 stress granules form in C9 CNs (***, p< .001, one-way ANOVA with
Dunnett’s post hoc test). Scale bars5 20 mm; scale bars in the bottom panels of (H)5 10 mm. Data are represented as average6 SEM.
Abbreviations: CNs, cortical neurons; DAPI, 40,6-diamidino-2-phenylindole; PABP, poly-A-binding protein.
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caspase-3 and cytochrome c in the patient-derived MNs and
CNs, indicating the C9 neurons are undergoing caspase-
dependent apoptosis.
Disruption of ER Ca21 homeostasis also plays a direct role in
the induction of ER stress by interfering with the function of
Ca21-sensitive ER chaperones [47]. Constitutive activation of
ER stress in C9orf72 MNs, which interestingly appears to be
greater in cells with a higher number of hexanucleotide
repeats, may contribute to the induction of ER-stress associ-
ated apoptosis. This is consistent with a previous study of
C9orf72-patient iPSC-derived MNs which found upregulation
of transcripts involved in UPR activation and ER stress [48].
While all MNs carrying repeats showed a survival deficit and an
active apoptotic pathway, only the patient-derived MNs with
large hexanucleotide expansions showed ER stress under base-
line conditions. These results suggest that ER stress is activated
by high numbers of pathogenic repeats but is not the exclusive
pathway in the induction of neuronal death. In accordance
with our observations, a similar study using SOD11/A4V iPSC-
derived MNs found elevated ER stress in patient MNs, but
treatment with salubrinal or knockdown of XBP-1 did not res-
cue the survival deficit, suggesting that ER stress is only one of
many components that may be contributing to MN death [48].
Selective neuronal vulnerability may involve specific combina-
tions of mutually reinforcing stressors and altered pathways
that ultimately converge on neuronal death [49]. Conse-
quently, the gradual increase of stress in an age-dependent
fashion in vulnerable MNs may underlie the progression of
neurodegeneration in ALS. Taken together, our results highlight
the importance of ER Ca21 regulation in different in vivo and in
vitro models and support the hypothesis that MN degenera-
tion in ALS is mediated by cell-type specific impairments in
intracellular Ca21 handling [50–52].
MNs and CNs from C9orf72 patients also showed high
levels of SQST1/p62, which is an adaptor molecule for selec-
tive autophagosomal degradation of ubiquitinated targets
and its accumulation reflects the inefficiency of protein
aggregate removal by the autophagic machinery [53].
SQST1/p62 is a common component of protein aggregates
found in neurodegenerative diseases, such as Lewy bodies
in Parkinson’s disease, neurofibrillary tangles in Alzheimer’s
disease, and in huntingtin aggregates [54–56]. Elevated p62
levels have previously been reported in CNs derived from
iPSCs of FTD patients carrying hexanucleotide expansions in
C9orf72, and it is a pathological marker in post-mortem
analysis from C9orf72 carriers [5, 7]. We detected high
SQST1/p62 levels in MNs under basal conditions without
changes in LC3-II/LC3-I turnover, indicating a reduced auto-
phagic flux in C9orf72 MNs compared to healthy controls.
Interestingly, elevated SQST1/p62 levels were correlated
with increased LC3-II in CNs from an ALS/FTD patient, sug-
gesting a potentially distinct accumulation of autophago-
somes in these cells and impairment in the autophagic
process, which is specific to the CNs and is not recapitu-
lated in MNs.
CONCLUSION
Our study identified several cellular phenotypes that associ-
ate with the repeat expansions in C9orf72 in MNs and CNs
and molecular changes that may account for their vulnerabil-
ity in pathological conditions. We have identified an apopto-
tic pathway that is activated in the C9orf72 neurons, which
involves ER calcium dysregulation and stress, followed by
mitochondrial alterations, the release of apoptotic factors
from the mitochondria, and the formation of stress granules.
It is unclear where this chain of phenotypes is initiated,
whether the presence of toxic RAN dipeptides induces ER
stress and dysregulation of calcium, or whether the presence
of the RNA foci leads to the recruitment of essential Ca21
regulators transcripts. Further work is currently underway to
analyze the molecular mechanism linking the hexanucleotide
repeats in C9orf72 and the neuronal phenotypes. In this
study, a high number of repeat expansions (>1,000) corre-
lated with a more severe phenotype in our patient MN cul-
tures, but a more extensive study is required to establish
whether there is a correlation between the number of
repeats and severity of the cellular phenotypes. Although
our observations suggest that the cellular phenotypes
observed are robust enough to be used to as a tool to
screen potential therapies, further work is required to estab-
lish the exact mechanistic relationship between the patho-
logical pathways activated in C9orf72 MNs, CNs, and
neurodegeneration.
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